Johnson & Johnson COVID-19 Vaccine
Important information for members
The U.S. Centers for Disease Control and Prevention (CDC) and the Food and Drug Administration (FDA) have recommended a pause in the use of the Johnson & Johnson (J&J) COVID-19 vaccine.
The agencies are reviewing data tied to six cases of a rare and severe type of blood clot in combination with low levels of blood platelets among individuals who received the J&J vaccine. While these events seem to be extremely rare, the CDC and FDA are recommending a pause in using the J&J vaccine out of an abundance of caution.
Please contact your health care provider if you have received the J&J vaccine within the last three weeks and develop severe headache, abdominal pain, leg pain or difficulty breathing.
We will continue to monitor and provide updates as the situation evolves. Please visit the CDC’s website for additional information: https://www.cdc.gov/media/releases/2021/s0413-JJ-vaccine.html